(Q38428196)

3 September 2017

title

Factors associated with hospitalization costs for patients with community-acquired pneumonia (English)

1 reference

3 September 2017

Factors associated with hospitalization costs for patients with community acquired pneumonia (English)

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(03)80099-1

2 January 2024

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(03)80099-1

2 January 2024

2

C. Daniel Mullins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749516

2 January 2024

3

Ya-Chen Tina Shih

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749516

2 January 2024

author name string

Sanjay Merchant

1

1 reference

3 September 2017

language of work or name

1 reference

1 February 2003

1 reference

full work available at URL

3 September 2017

https://api.elsevier.com/content/article/PII:S0149291803800991?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(03)80099-1

https://api.elsevier.com/content/article/PII:S0149291803800991?httpAccept=text/plain

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(03)80099-1

2 January 2024

published in

Clinical Therapeutics

1 reference

3 September 2017

volume

25

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

593-610

1 reference

Community-acquired pneumonia

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

The cost of treating community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four-hospital study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

Critical pathways as a strategy for improving care: problems and potential

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

A Simple Test for Heteroscedasticity and Random Coefficient Variation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

Smearing Estimate: A Nonparametric Retransformation Method

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980099-1

7 January 2021

multicollinearity

20

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(03)80099-1

2 January 2024

multicollinearity

21

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(03)80099-1

2 January 2024

heteroscedasticity

24

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(03)80099-1

2 January 2024

Identifiers

1 reference

3 September 2017

1 reference